NasdaqCM - Delayed Quote USD
Eyenovia, Inc. (EYEN)
At close: November 7 at 4:00 PM EST
After hours: November 7 at 5:15 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.4M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROWE MICHAEL M Chief Executive Officer | Purchase at price 0.52 per share. | Direct | 14,077 | Aug 28, 2024 |
| ROWE MICHAEL M Chief Executive Officer | Purchase at price 0.57 per share. | Direct | 28,500 | Aug 26, 2024 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.66 per share. | Direct | 1,000,000 | Jul 2, 2024 |
| GELTZEILER MICHAEL S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| MATHER CHARLES E IV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| STRAHLMAN ELLEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| IANCHULEV TSONTCHO Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| JACOBSON RACHEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| PALANKI RAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.98 per share. | Direct | 98,000 | Mar 28, 2024 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.23 per share. | Direct | 61,480 | Mar 19, 2024 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.58 per share. | Direct | 16,911 | Mar 8, 2024 |
| ROWE MICHAEL M Chief Executive Officer | Purchase at price 1.36 per share. | Direct | 6,650 | Dec 4, 2023 |
| GELTZEILER MICHAEL S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 14, 2023 |
| STRAHLMAN ELLEN Director | Purchase at price 1.68 per share. | Direct | 8,098 | Sep 29, 2023 |
| ROWE MICHAEL M Chief Executive Officer | Purchase at price 1.66 - 1.75 per share. | Direct | 4,314 | Sep 19, 2023 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.87 - 1.91 per share. | Direct | 141,915 | Aug 17, 2023 |
| MATHER CHARLES E IV Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
| STRAHLMAN ELLEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
| IANCHULEV TSONTCHO Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
| JACOBSON RACHEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
| PALANKI RAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 27, 2023 |
| GANDOLFO JOHN P Chief Financial Officer | Purchase at price 2.79 per share. | Direct | 5,580 | May 31, 2023 |
| KERN BREN Chief Operating Officer | Purchase at price 2.73 per share. | Direct | 6,825 | May 26, 2023 |
| MATHER CHARLES E IV Director | Purchase at price 2.49 per share. | Direct | 7,470 | May 26, 2023 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.65 per share. | Direct | 233,855 | May 25, 2023 |
| STRAHLMAN ELLEN Director | Purchase at price 3.10 per share. | Direct | 30,976 | May 23, 2023 |
| MATHER CHARLES E IV Director | Purchase at price 3.39 per share. | Direct | 13,560 | May 15, 2023 |
| ROWE MICHAEL M Chief Executive Officer | Conversion of Exercise of derivative security at price 2.72 per share. | Direct | 27,200 | May 1, 2023 |
| IANCHULEV TSONTCHO Director | Sale at price 5.50 per share. | Direct | 495,000 | May 1, 2023 |
| IANCHULEV TSONTCHO Director | Sale at price 5.00 per share. | Direct | 300,000 | Apr 27, 2023 |
| IANCHULEV TSONTCHO Director | Sale at price 4.50 per share. | Direct | 180,000 | Apr 14, 2023 |
| IANCHULEV TSONTCHO Director | Sale at price 4.00 per share. | Direct | 160,000 | Apr 11, 2023 |
| IANCHULEV TSONTCHO Director | Sale at price 3.50 per share. | Direct | 140,000 | Mar 31, 2023 |
| ROWE MICHAEL M Chief Executive Officer | Purchase at price 1.54 per share. | Direct | 15,400 | Dec 30, 2022 |
| GRANT STUART M Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.50 per share. | Direct | 32,630 | Dec 30, 2022 |
Related Tickers
ATRA Atara Biotherapeutics, Inc.
10.10
+0.95%
TPST Tempest Therapeutics, Inc.
1.0600
+1.92%
LYRA Lyra Therapeutics, Inc.
0.2650
-5.32%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9409
+0.85%
ENSC Ensysce Biosciences, Inc.
0.6957
+26.42%
TVGN Tevogen Bio Holdings Inc.
1.1400
-12.31%
MIST Milestone Pharmaceuticals Inc.
1.9500
+8.94%
SLS SELLAS Life Sciences Group, Inc.
1.1600
0.00%
IRD Opus Genetics, Inc.
1.0900
-6.84%
UNCY Unicycive Therapeutics, Inc.
0.5698
+13.51%